Clinical Trial Update: Randomized Trial of Glutamine in Patients With Mucositis or Esophagitis [Phase 3]

View source ↗

Summary

Phase 3 randomized trial of glutamine for mucositis or esophagitis in patients with advanced cancers was terminated; results posted in 2022.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Drugs mentioned

• Glutamine (glutamine)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Advanced Cancers | Phase 3 | Status: TERMINATED | Results posted: 2022-06-15